BeOne Medicines (ONC) EPS (Basic) (QoQ) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn |
| 10 | BeOne Medicines | - | - | 1.35 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 300.00% |
| Dec 31, 2025 | -55.56% |
| Sep 30, 2025 | 28.57% |
| Dec 31, 2024 | -22.22% |
| Sep 30, 2024 | 0.00% |
| Jun 30, 2024 | 52.63% |
| Mar 31, 2024 | 29.63% |
| Dec 31, 2023 | -268.75% |
| Sep 30, 2023 | 157.14% |
| Jun 30, 2023 | -7.69% |
| Mar 31, 2023 | 21.21% |
| Dec 31, 2022 | 19.51% |
| Sep 30, 2022 | 2.38% |
| Jun 30, 2022 | -27.27% |
| Mar 31, 2022 | 32.65% |
| Dec 31, 2021 | -36.11% |
| Sep 30, 2021 | 10.00% |
| Jun 30, 2021 | -766.67% |
| Mar 31, 2021 | 115.00% |
| Dec 31, 2020 | -8.11% |
| Sep 30, 2020 | -12.12% |
| Jun 30, 2020 | 8.33% |
| Mar 31, 2020 | 26.53% |
| Dec 31, 2019 | -25.64% |
| Sep 30, 2019 | -254.55% |
| Jun 30, 2019 | 50.00% |
| Mar 31, 2019 | 37.14% |
| Dec 31, 2018 | -84.21% |
| Sep 30, 2018 | 13.64% |
| Jun 30, 2018 | -37.50% |
| Mar 31, 2018 | 5.88% |
| Dec 31, 2017 | -180.95% |
| Sep 30, 2017 | 275.00% |
| Jun 30, 2017 | -20.00% |
| Mar 31, 2017 | -25.00% |
| Dec 31, 2016 | 0.00% |
| Sep 30, 2016 | -33.33% |
| Jun 30, 2016 | 14.29% |
| Mar 31, 2016 | 69.57% |
| Dec 31, 2015 | -76.92% |
| Sep 30, 2015 | -160.00% |
| Jun 30, 2015 | 44.44% |